Page last updated: 2024-11-13

glucosaminylmuramyl-2-alanine-d-isoglutamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

glucosaminylmuramyl-2-alanine-D-isoglutamine: the epitope of peptidoglycan [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID118984439
MeSH IDM0175090

Synonyms (16)

Synonym
d-alpha-glutamine, n2-(n-(n-acetyl-o-(2-amino-2-deoxy-beta-d-glucopyranosyl)muramoyl)-l-alanyl)-
glucosaminyl-mdp
glucosaminylmuramyl dipeptide
glucosaminyl-muramyl-dipeptide
gmpd
glucosaminylmuramyl-2-alanine-d-isoglutamine
97590-38-0
unii-755sxx41rz
d-glutamine, n-(n-acetyl-4-o-(2-amino-2-deoxy-beta-d-glucopyranosyl)-beta-muramoyl)-l-alanyl-
glucosaminylmuramyl dipeptide [who-dd]
d-glutamine, n-(n-acetyl-4-o-(2-amino-2-deoxy-.beta.-d-glucopyranosyl)-.beta.-muramoyl)-l-alanyl-
d-.alpha.-glutamine, n2-(n-(n-acetyl-o-(2-amino-2-deoxy-.beta.-d-glucopyranosyl)muramoyl)-l-alanyl)-
755SXX41RZ ,
188123-33-3
(2r)-2-[[(2s)-2-[[(2r)-2-[(2r,3r,4r,5s,6r)-3-acetamido-5-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoyl]amino]propanoyl]amino]-5-amino-5-oxopentanoic acid
Q27266349

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The bioavailability (BA) of radio-labelled N-acetylglucosaminyl-N-acetylmuramyl dipeptide (GMDP) was low when administered by oral gavage as an aqueous solution to conscious male Sprague-Dawley rats (8."( Factors limiting the oral bioavailability of N-acetylglucosaminyl-N-acetylmuramyl dipeptide (GMDP) and enhancement of absorption in rats by delivery in a water-in-oil microemulsion.
Charman, WN; Lyons, KC; Miller, R; Porter, CJ, 2000
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.63)18.7374
1990's18 (47.37)18.2507
2000's9 (23.68)29.6817
2010's10 (26.32)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.91

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.91 (24.57)
Research Supply Index3.97 (2.92)
Research Growth Index5.88 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.91)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (6.12%)5.53%
Reviews3 (6.12%)6.00%
Case Studies1 (2.04%)4.05%
Observational0 (0.00%)0.25%
Other42 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]